Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Remix Therapeutics
Remix Therapeutics
Seagen Inc.
VM Oncology, LLC
Rgenta Therapeutics Inc
Mersana Therapeutics
Novelty Nobility, Inc.
HitGen Inc.
Poseida Therapeutics, Inc.
Elevar Therapeutics
Ayala Pharmaceuticals, Inc,
Cellestia Biotech AG
Ayala Pharmaceuticals, Inc,
Prelude Therapeutics
Actuate Therapeutics Inc.
CureVac
Cogent Biosciences, Inc.
Novartis